G3BP1 and Neurodevelopmental delay: Furthermore, the statistical data based on 40,853 individuals with NDDs and the subsequent functional evidence supported that de novo mutations (DNMs) in the essential SG genes, such as G3BP1, G3BP2, and CAPRIN1, are associated with NDD risk.